0001179110-18-002981.txt : 20180227
0001179110-18-002981.hdr.sgml : 20180227
20180227172653
ACCESSION NUMBER: 0001179110-18-002981
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180223
FILED AS OF DATE: 20180227
DATE AS OF CHANGE: 20180227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kumar Ramesh
CENTRAL INDEX KEY: 0001580074
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36020
FILM NUMBER: 18646576
MAIL ADDRESS:
STREET 1: 375 PHEASANT RUN
CITY: NEWTOWN
STATE: PA
ZIP: 18940
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Onconova Therapeutics, Inc.
CENTRAL INDEX KEY: 0001130598
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 375 PHEASANT RUN
CITY: NEWTOWN
STATE: PA
ZIP: 18940
BUSINESS PHONE: 267-759-3681
MAIL ADDRESS:
STREET 1: 375 PHEASANT RUN
CITY: NEWTOWN
STATE: PA
ZIP: 18940
FORMER COMPANY:
FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20090526
FORMER COMPANY:
FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS INC
DATE OF NAME CHANGE: 20001226
4
1
edgar.xml
FORM 4 -
X0306
4
2018-02-23
0
0001130598
Onconova Therapeutics, Inc.
ONTX
0001580074
Kumar Ramesh
C/O ONCONOVA THERAPEUTICS, INC.
375 PHEASANT RUN
NEWTOWN
PA
18940
1
1
0
0
President and CEO
Stock Option (right to purchase)
1.09
2018-02-23
4
A
0
73220
0
A
2018-02-23
2028-02-23
Common Stock
73220
73220
D
This option grant was made in lieu of cash payment for a portion of Dr. Kumar's year-end bonus. The options vest immediately.
/s/ Ramesh Kumar
2018-02-27